Welcome to our dedicated page for Cognyte Software SEC filings (Ticker: CGNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cognyte Software Ltd. filings document foreign private issuer current reports for an investigative analytics software company. Its Form 6-K reports furnish earnings releases, conference-call announcements and GAAP condensed financial statements, with selected financial information incorporated by reference into Form S-8 registration statements.
The filing record also covers capital-allocation actions such as ordinary-share repurchase authorizations, including open-market and privately negotiated purchase mechanics under U.S. securities rules. Governance disclosures include annual shareholder meeting materials, proxy cards, director-election proposals, voting procedures, quorum information and voting results for holders of ordinary shares.
Cognyte Software Ltd.’s Chief Financial Officer David Abadi filed a Form 3 showing beneficial ownership of 1,026,792 Ordinary Shares, held directly. This total includes performance share units and restricted share units that will settle into Ordinary Shares as they vest between 2026 and 2028.
The holdings comprise 172,532 Ordinary Shares represented by PSUs granted on March 26, 2024, which will vest on April 11, 2026, and multiple blocks of RSUs: 18,334 shares vesting May 10, 2026, 46,291 shares vesting in three tranches from March 2026 to March 2027, 76,885 shares vesting in five tranches from March 2026 to March 2028, and 90,305 shares vesting in six semi-annual installments over three years from March 16, 2026.
Cognyte Software Ltd. director Nurit Benjamini filed an initial ownership report showing holdings tied to 40,022 Ordinary Shares. These are entirely represented by restricted share units granted on March 31, 2025 and March 16, 2026, with vesting scheduled through March 24, 2027.
Cognyte Software Ltd. director Matthew K. O'Neill filed an initial ownership report showing beneficial ownership of 40,022 Ordinary Shares. This includes 19,048 shares represented by restricted share units (RSUs) granted on March 24, 2025 that vest on March 24, 2026, and 20,974 shares represented by RSUs granted on March 16, 2026 that vest in four equal quarterly installments over one year. The filing records current holdings and does not reflect any recent share purchases or sales.
Cognyte Software Ltd. director Ron Shvili filed an initial ownership report showing beneficial ownership of 75,853 Ordinary Shares. This includes time-based restricted share units that convert into shares if vesting conditions are met.
The holdings include 7,263 Ordinary Shares represented by RSUs granted on May 1, 2024, with 3,632 vesting on May 1, 2026 and 3,631 vesting on May 1, 2027. They also include 19,048 Ordinary Shares represented by RSUs granted on March 24, 2025 that vest on March 24, 2026, and 20,974 Ordinary Shares represented by RSUs granted on March 16, 2026 that vest in four equal quarterly installments over the following year.
Cognyte Software Ltd. director Avi Cohen filed an initial Form 3 reporting beneficial ownership of 102,828 Ordinary Shares. This total includes time-based restricted share units that convert into ordinary shares as they vest.
The holdings include 5,079 shares represented by RSUs granted on June 4, 2023, vesting on June 4, 2026, 19,048 shares represented by RSUs granted on March 24, 2025, vesting on March 24, 2026, and 20,974 shares represented by RSUs granted on March 16, 2026, which vest in four equal quarterly installments over the following year.
Cognyte Software Ltd. director Dafna Sharir filed an initial statement of ownership showing 126,450 Ordinary Shares held directly. This amount includes 19,048 shares represented by RSUs granted on March 24, 2025 that vest on March 24, 2026, and 20,974 shares represented by RSUs granted on March 16, 2026 that vest in four equal quarterly installments over one year.
Cognyte Software Ltd. director Sharon Elad has filed an initial ownership report showing beneficial ownership of 2,167,671 Ordinary Shares. This total includes time-based restricted share units and performance share units that convert into Ordinary Shares as they vest over the next several years.
The holdings include awards such as RSUs granted on September 7, 2023 that vest on May 10, 2026, PSUs granted on March 26, 2024 and September 4, 2024 that vest on April 11, 2026, and multiple RSU grants from 2024 and 2025–2026 with staggered vesting dates through March 24, 2028.
Cognyte Software Ltd. director Earl C. Shanks filed an initial ownership report showing beneficial ownership of 293,075 Ordinary Shares, held directly. This total includes 19,048 Ordinary Shares represented by restricted share units granted on March 24, 2025 that vest on March 24, 2026, and 20,974 Ordinary Shares represented by restricted share units granted on March 16, 2026 that vest in four equal quarterly installments over one year.
Cognyte Software Ltd. filed a Form 6-K to notify investors that it will hold a conference call on March 25, 2026 at 8:30am ET to review its fourth quarter and full-year fiscal 2026 results for the period ending January 31, 2026.
An earnings press release will be issued before the call, and a live webcast with presentation slides will be available through the Investor Relations section of Cognyte’s website, with phone access available to those who register for dial-in details.
Cognyte Software Ltd. has increased its share repurchase authorization, with the board approving an additional $20 million for buybacks. This is the company’s third $20 million approval since launching the program in November 2024.
The new authorization brings the total amount approved for share repurchases to $40 million. Of the original $20 million authorization, about $8.9 million had been used before this increase. Repurchases may be made through open market purchases, privately negotiated transactions or other methods, and can be suspended or discontinued at any time.
Buybacks under the added authorization may begin after a 30-day creditor objection period required under Israeli regulations. Cognyte expects to fund repurchases using cash on its balance sheet and ongoing cash flow generation, with repurchased shares available for general corporate purposes.